


Searching News Database: Biosite
HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
HSMN NewsFeed - 26 Oct 2010
AspenBio Advances AppyScore(TM) Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise
AspenBio Advances AppyScore(TM) Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise
HSMN NewsFeed - 1 May 2008
Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
HSMN NewsFeed - 18 Mar 2008
Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
HSMN NewsFeed - 15 May 2007
Beckman Coulter Advises It Will Not Increase Its Offer to Acquire Biosite Beyond $90.00 Per Share
Beckman Coulter Advises It Will Not Increase Its Offer to Acquire Biosite Beyond $90.00 Per Share
HSMN NewsFeed - 14 May 2007
Biosite Determines That Revised Binding Offer From Inverness Constitutes a 'Superior Proposal'
Biosite Determines That Revised Binding Offer From Inverness Constitutes a 'Superior Proposal'
HSMN NewsFeed - 10 May 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
HSMN NewsFeed - 10 May 2007
Biosite Receives Revised Offer From Inverness Medical Regarding Possible Cash Tender Offer
Biosite Receives Revised Offer From Inverness Medical Regarding Possible Cash Tender Offer
HSMN NewsFeed - 24 Apr 2007
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer
HSMN NewsFeed - 17 Apr 2007
Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
HSMN NewsFeed - 17 Apr 2007
Beckman Coulter Proposed Acquisition of Biosite Passes Milestone With U.S. Regulatory Approval
Beckman Coulter Proposed Acquisition of Biosite Passes Milestone With U.S. Regulatory Approval
HSMN NewsFeed - 10 Apr 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
HSMN NewsFeed - 9 Apr 2007
Biosite Fails to Respond to Inverness' Superior Proposal of $90.00 Per Share in Cash
Biosite Fails to Respond to Inverness' Superior Proposal of $90.00 Per Share in Cash
HSMN NewsFeed - 5 Apr 2007
Inverness Confirms Proposal to Acquire Biosite for $90.00 Per Share in Cash
Inverness Confirms Proposal to Acquire Biosite for $90.00 Per Share in Cash
Additional items found! 42
Members Archive contains
42 additional stories matching:
Biosite
(Password required)
Biosite
(Password required)
